Naomi Wolf’s “Pfizer Papers” exposes serious vaccines’ health risks

Naomi Wolf, editor of “The Pfizer Papers: Pfizer’s Crimes Against Humanity,” claims that both Pfizer and the U.S. Food and Drug Administration (FDA) were aware of the severe adverse effects of the COVID-19 vaccine early on, yet continued to promote its use.

Wolf, a prominent journalist, discussed her findings in a recent interview with The Defender, alleging that Pfizer manipulated data and delayed reporting deaths linked to the vaccine.

According to Wolf, Pfizer and the FDA were already aware of vaccine-related injuries by early 2021, based on clinical trials and post-marketing studies. Wolf, along with Amy Kelly, Chief Operations Officer at Daily Clout, organized a team of scientists to investigate Pfizer’s internal documents.

These records, released in 2022 after a lawsuit by Public Health and Medical Professionals for Transparency, revealed troubling findings, including 42,000 reports of adverse events, most of which affected women.

READ ALSO: Moderna faces shareholder lawsuit over misleading RSV vaccine efficacy claims

One of the most shocking findings, Wolf said, was the severe reproductive harm the vaccine caused in women. Pfizer’s own data showed that 72% of the recorded adverse events occurred in women, with 16% involving reproductive disorders.

Wolf described widespread cases of hemorrhaging, menstrual cycle disruptions, and even warnings from Pfizer to vaccinated men to avoid unprotected intercourse with women of childbearing age.

Wolf also highlighted Pfizer’s deliberate delay in reporting deaths associated with the vaccine to secure emergency use authorization (EUA) from the FDA. Had these deaths been reported in time, Wolf argues, the EUA might not have been granted.

Court-Ordered Data Release: In 2021, the FDA was sued to release documents related to the Pfizer vaccine. The federal court ordered the release of 450,000 internal documents in 2022, which Wolf and her team analyzed.

The documents exposed 158,893 adverse events, including serious conditions such as blood clots, liver and kidney damage, and neurological disorders. The data also showed that Pfizer had to hire over 600 additional employees just to process the influx of reports.

Impact on Mothers and Infants: Wolf stressed that the vaccine’s harmful effects extended to pregnancy and childbirth. Pfizer knew that lipid nanoparticles from the vaccine accumulated in the ovaries and crossed the placental barrier, compromising fetal health.

Wolf pointed out that the FDA received Pfizer’s pregnancy and lactation report in April 2021, yet two days later, CDC Director Rochelle Walensky publicly reassured women that it was safe to take the vaccine during pregnancy.

READ ALSO: Novavax COVID-Flu vaccine trial suspended after participant reports nerve damage

The report’s findings, which included infants suffering from fever, vomiting, and, in one case, multi-organ failure, horrified Wolf. She emphasized that despite knowing the risks, Pfizer continued promoting the vaccine without advising breastfeeding mothers to stop.

Wolf, once a respected voice in liberal media, claims she was silenced after raising concerns about the vaccine’s side effects. She explained that after tweeting about menstrual irregularities linked to the shots, she was deplatformed from all major social media platforms and subjected to a wave of negative press.

In her interview, Wolf criticized the mainstream media for ignoring this “biggest story of the 21st century.” She expressed frustration that outlets like The New York Times and The Washington Post refused to cover the revelations in The Pfizer Papers.

Wolf believes the documents show a clear disregard for public health and accuses Pfizer and the FDA of knowingly risking lives.

However, she also finds hope in the scientific analysis included in The Pfizer Papers, suggesting that understanding how the vaccine caused harm may lead to ways of mitigating its effects for those who suffered injuries. Wolf’s research continues to fuel debates over vaccine transparency and corporate responsibility.